Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals reported 2 insider transactions totaling $97,222.74. Activity split between 1 tax payment of $18,400.36 and 1 sale of $78,822.38. Average transaction value:$48,611.37; ...